Jurnista

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

White, round, biconvex tablet with 'HM32' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Red, round, biconvex tablet with 'HM8' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Red, round, biconvex tablet with 'HM8' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Red, round, biconvex tablet with 'HM8' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Yellow, round, biconvex tablet with 'HM16' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on August 1, 2022. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Yellow, round, biconvex tablet with 'HM16' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

White, round, biconvex tablet with 'HM32' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Blue, round, biconvex tablet with 'HM64' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Yellow, round, biconvex tablet with 'HM16' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Red, round, biconvex tablet with 'HM8' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on August 1, 2022. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

White, round, biconvex tablet with 'HM32' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Yellow, round, biconvex tablet with 'HM16' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Blue, round, biconvex tablet with 'HM64' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Red, round, biconvex tablet with 'HM8' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Red, round, biconvex tablet with 'HM8' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Yellow, round, biconvex tablet with 'HM16' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Blue, round, biconvex tablet with 'HM64' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

White, round, biconvex tablet with 'HM32' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Red, round, biconvex tablet with 'HM8' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Blue, round, biconvex tablet with 'HM64' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Pale beige, round, biconvex tablet with "HM 4" printed in black ink on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Yellow, round, biconvex tablet with 'HM16' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

White, round, biconvex tablet with 'HM32' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Blue, round, biconvex tablet with 'HM64' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Red, round, biconvex tablet with 'HM8' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Blue, round, biconvex tablet with 'HM64' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

White, round, biconvex tablet with 'HM32' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Blue, round, biconvex tablet with 'HM64' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Red, round, biconvex tablet with 'HM8' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

White, round, biconvex tablet with 'HM32' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Blue, round, biconvex tablet with 'HM64' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

White, round, biconvex tablet with 'HM32' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

White, round, biconvex tablet with 'HM32' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Yellow, round, biconvex tablet with 'HM16' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Yellow, round, biconvex tablet with 'HM16' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

White, round, biconvex tablet with 'HM32' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Blue, round, biconvex tablet with 'HM64' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

White, round, biconvex tablet with 'HM32' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on August 1, 2022. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Red, round, biconvex tablet with 'HM8' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Yellow, round, biconvex tablet with 'HM16' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Yellow, round, biconvex tablet with 'HM16' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Blue, round, biconvex tablet with 'HM64' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Blue, round, biconvex tablet with 'HM64' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on August 1, 2022. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Red, round, biconvex tablet with 'HM8' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Pale beige, round, biconvex tablet with "HM 4" printed in black ink on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on August 1, 2022. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Yellow, round, biconvex tablet with 'HM16' printed in black on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Pale beige, round, biconvex tablet with "HM 4" printed in black ink on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Pale beige, round, biconvex tablet with "HM 4" printed in black ink on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Pale beige, round, biconvex tablet with "HM 4" printed in black ink on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Pale beige, round, biconvex tablet with "HM 4" printed in black ink on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Pale beige, round, biconvex tablet with "HM 4" printed in black ink on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Pale beige, round, biconvex tablet with "HM 4" printed in black ink on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Pale beige, round, biconvex tablet with "HM 4" printed in black ink on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Pale beige, round, biconvex tablet with "HM 4" printed in black ink on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What it is used for

JURNISTA is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. JURNISTA is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. JURNISTA is not indicated as an as-needed (PRN) analgesia. Not for use in opioid naïve patients.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

Store below 25 degrees Celsius
Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Pale beige, round, biconvex tablet with "HM 4" printed in black ink on one side.

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

Over 65?

This medicine contains the active ingredients:

hydromorphone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient hydromorphone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Consumer Medicines Information (CMI)

For side effects, taking other medicines and more

Print the CMI.

Listen to the CMI.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

What it is used for

How to take it

Visual appearance

Do I need a prescription?

What is the medicines and poisons schedule?

Over 65?

Pregnant or planning a pregnancy?

Consumer Medicines Information (CMI)

Reporting side effects

What it is used for

How to take it

Visual appearance

Do I need a prescription?

What is the medicines and poisons schedule?

Over 65?

Pregnant or planning a pregnancy?

Consumer Medicines Information (CMI)

Reporting side effects

What it is used for

How to take it

Visual appearance

Do I need a prescription?

What is the medicines and poisons schedule?

Over 65?

Pregnant or planning a pregnancy?

Consumer Medicines Information (CMI)

Reporting side effects

What it is used for

How to take it

Visual appearance

Do I need a prescription?

What is the medicines and poisons schedule?

Over 65?

Pregnant or planning a pregnancy?

Consumer Medicines Information (CMI)

Reporting side effects

What it is used for

How to take it

Visual appearance

Do I need a prescription?

What is the medicines and poisons schedule?

Is this medicine subsidised?

Over 65?

Pregnant or planning a pregnancy?

Consumer Medicines Information (CMI)

Reporting side effects

What it is used for

How to take it

Visual appearance

Do I need a prescription?

What is the medicines and poisons schedule?

Over 65?

Pregnant or planning a pregnancy?

Consumer Medicines Information (CMI)

Reporting side effects

What it is used for

How to take it

Visual appearance

Do I need a prescription?

What is the medicines and poisons schedule?

Over 65?

Pregnant or planning a pregnancy?

Consumer Medicines Information (CMI)

Reporting side effects

What it is used for

How to take it

Visual appearance

Do I need a prescription?

What is the medicines and poisons schedule?

Over 65?

Pregnant or planning a pregnancy?

Consumer Medicines Information (CMI)

Reporting side effects

What it is used for

How to take it

Visual appearance

Do I need a prescription?

What is the medicines and poisons schedule?

Over 65?

Pregnant or planning a pregnancy?